Access cutting-edge diffuse large b-cell lymphoma treatment through this clinical trial at a research site in Fayetteville. Study-provided care at no cost to qualified participants.
Access diffuse large b-cell lymphoma specialists in Fayetteville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diffuse large b-cell lymphoma treatment provided free
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin helps benefit patients who have received chemotherapy (fludarabine and cyclophosphamide) followed by chimeric antigen receptor (CAR) T-cell therapy (tisagenlecleucel, axicabtagene ciloleucel, or lisocabtagene maraleucel) for diffuse large B-cell lymphoma that has come back (recurrent) or that does not respond to treatment (refractory) or grade IIIb follicular lymphoma. Mosunetuzumab is a monoclonal antibody that may inter
Sponsor: SWOG Cancer Research Network
Check if you qualify for this diffuse large b-cell lymphoma clinical trial in Fayetteville, AR
If you're searching for diffuse large b-cell lymphoma treatment options in Fayetteville, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fayetteville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diffuse large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.